AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $0
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 10.00am 07/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 0.0¢ | Day High | 0.0¢ | Day Low | 0.0¢ | |||
| Daily Volume | 0 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 1.0¢ | 0 | 0 | 1.1¢ | 0 | |
Directors & Senior Management
| Mr. Damiain Brown | Chief Product Officer |
| Mr. George Lazarou | Company Secretary |
| Mr. Jaron Leigh Warburton | Chief Innovation & Technology Officer |
| Mr. Jason Chong | Group Chief Financial Officer |
| Major Jeffery Sengelman | Executive Chairman |
| Mr. Jimmy Dean | Founder & Head of Solution Architecture |
| Mr. Marcus Machin | Non-Executive Independent Director |
| Mr. Richard Coston | Head of Regional Sales - APAC |
| Mr. Ross Mckinnon | Independent Non-Executive Director |
Data source: ADVFN
